What is Shandong Boyuan Pharmaceutical & Chemical Co., Ltd.'s (301617.SZ) StockRank?

MoatMap's StockRank for Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. (301617.SZ) is 29/100, with a Sell signal. This is a composite score combining Quality (70), Value (19), and Momentum (31) factor ranks across MoatMap's 20,000+ stock universe.

Does Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. have an economic moat?

Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. (301617.SZ) has a Quality factor score of 70/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. (301617.SZ) is Sell, based on a StockRank of 29/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. in?

Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. (301617.SZ) operates in the Basic Materials sector, specifically the Chemicals industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

301617.SZ

SELLFLAG

Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. · Basic Materials · China · $1.3B · Avg Vol: $37M/d

StockRank

P/E (TTM)

54.9x

ROE

10.1%

D/E

0.0x

Dividend %

0.6%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Shandong Boyuan Pharmaceutical is a high-quality (Q: 70) manufacturer of active pharmaceutical ingredients (APIs) and intermediates. It stands to benefit from the CDMO pricing power cycle as global pharma seeks validated, high-quality manufacturing partners. However, geopolitical risks surrounding Chinese chemical suppliers prevent a high-conviction buy.

COMPANY DESCRIPTION

Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. specializes in the R&D and production of fine chemicals, active pharmaceutical ingredients (APIs), and intermediates, with a dominant position in iodinated contrast agent raw materials. The company leverages advanced green chemistry and continuous flow reaction technologies to achieve high-yield, eco-friendly production. Its competitive moat is secured by its leading global market share in iodine-based intermediates and strict compliance with international pharmaceutical quality standards.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR
Revenue	118M	152M	196M	216M	22.4%
EPS	0.26	0.35	0.31	0.19	-9.8%
Shares	77M	77M	103M	134M	+73.3%
Debt	380,715	78,029	39,803	271,102	-10.7%
Equity	0	120M	245M	255M	46.2%
Op CF	28M	22M	24M	-438,982	-7.5%
Inv CF	-27M	528,888	-8M	-74M	—
Fin CF	-94,189	-484,574	93M	-14M	—

PRICE (1M)-7.9%

SMA 50SMA 200

$8.35

RSI (14)

60.1

52W High

$12.46

From 52W High

0.7%

SCORE BREAKDOWN

Quality

ROIC

11.3%78.7

ROE

10.1%73.1

GP/Assets

15.4%58.7

Op. Margin

14.6%75.6

FCF/Assets

-9.6%25.4

Piotroski

—51.5

Int. Cover

50.0x93.3

D/E Ratio

0.00x97.9

Current Ratio

7.07x84.8

Value

P/E (TTM)

54.9x19.3

EV/EBITDA

37.1x9.1

P/FCF

—N/A

P/B

5.4x17.2

P/S

6.2x20.6

Div Yield

0.6%23.6

Momentum

52W High %

67%39.2

RS 6M

-17%37.8

SMA 50/200

0.89x12.9

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

4%36.3

FUNDAMENTALS

Market Cap

$1.3B

P/E (Forward)

—

Gross Margin

19.2%

SECTOR PEERS

Closest peers in Basic Materials, ranked by industry match, size, and score similarity. Cross-listings of 301617.SZ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
301617.SZ	Shandong Boyuan Pharmaceutical & Chemical Co., Ltd.(you)	$1.3B	29	SELL
600929.SS	Snowsky Salt Industry Group CO.,LTD	$1.3B	28	SELL
000059.SZ	North Huajin Chemical Industries Co.,Ltd	$1.0B	27	SELL
600955.SS	Lihuayi Weiyuan Chemical Co., Ltd.	$1.3B	22	SELL
300706.SZ	Fujian Acetron New Materials Co., Ltd.	$1.1B	32	SELL
600618.SS	Shanghai Chlor-Alkali Chemical Co., Ltd.	$1.8B	31	SELL
603612.SS	Sunstone Development Co., Ltd.	$1.5B	35	SELL
301069.SZ	Shandong Kaisheng New Materials Co.,Ltd.	$1.3B	20	SELL
300856.SZ	Nanjing COSMOS Chemical Co., Ltd.	$894M	30	SELL
002971.SZ	Hubei Heyuan Gas Co.,Ltd.	$1.1B	23	SELL

Peer medians: ROE 6.1% · P/E 33.1x · Gross margin 17.5%

Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. (301617.SZ) — Stock Score Summary

Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. (301617.SZ) has a MoatMap StockRank of 29/100 based on Quality (70/100), Value (19/100), and Momentum (31/100) factor scores. The current signal is SELL. Shandong Boyuan Pharmaceutical is a high-quality (Q: 70) manufacturer of active pharmaceutical ingredients (APIs) and intermediates. It stands to benefit from the CDMO pricing power cycle as global pharma seeks validated, high-quality manufacturing partners. However, geopolitical risks surrounding Chinese chemical suppliers prevent a high-conviction buy.

Key Financial Metrics

Price	$8.35
Market Cap	$1.3B
P/E (TTM)	54.86
Price/Book	5.35
Return on Equity	10.1%
Return on Invested Capital	11.3%
Debt/Equity	0.07
Gross Margin	19.2%
Operating Margin	14.6%
Revenue Growth	22.1%
Dividend Yield	0.6%
Free Cash Flow	$-4M

Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. operates in the Chemicals industry, part of the Basic Materials sector (China).

Frequently Asked Questions

What is Shandong Boyuan Pharmaceutical & Chemical Co., Ltd.’s (301617.SZ) StockRank?: MoatMap’s StockRank for Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. (301617.SZ) is 29/100, with a Sell signal. It is a composite of Quality (70), Value (19), and Momentum (31) factor ranks across MoatMap’s 20,000+ stock universe.
Does Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. have an economic moat?: Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. (301617.SZ) has a Quality factor score of 70/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. (301617.SZ) is Sell, based on a StockRank of 29/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. in?: Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. (301617.SZ) operates in the Basic Materials sector, specifically the Chemicals industry (China).